Please find the preliminary Program below, which will be updated as further information is available. 

Thursday 14 June

  Plenary Room Morrison Room Theatre Brevet Lounge
0900 - 1030 Cardiovascular Nurses Symposium Acute Coronary Syndrome in the Regions  Imaging Working Group Registrar Training
 

Nurse, Educator, Scholar and CEO: Making an impact in nursing,  L Worrall-Carter

Auckland District Health Board snapshot of cardiac rehabilitations in New Zealand, C Gasparini

Outpatient Telehealth Cardiology Clinics – a new initiative?, L Smith

Panel Discussion

Acute Coronary Syndrome with no cath lab on site, V Pera

Acute Coronary Syndrome but only angiography, I Ternouth

Acute Coronary Syndrome with a regional percutaneous coronary intervention centre, T Pegg

Southern Australia regional Acute Coronary Syndrome program, S Nicholls

Cardiac magnetic resonance imaging, infiltrative cardiomyopathies, J Martin

New Zealand normal ranges for the left ventricle, G Whalley

Valvular heart disease, A To 

Working Group Meeting

20 spot echo diagnoses, P Bridgman

Electrophysiology for dummies, M Daly

Why you should pursue Academic career, R Troughton

Heart Foundation fellowships, G Devlin

 

1030 - 1100 Morning Tea
1100 - 1230 Cardiovascular Nurses Symposium (continues) Interventional Working Group Heart Rhythm Working Group Registrar Training (continues)
 

  Nurse led rapid access chest pain clinic, TBC

ACS project, N Lumb

Skills and knowledge framework, W Bryson

Working Group Meeting

Indications for high risk interventional candidates in a peripheral centre, KL Chow

Role of thrombolysis (drip and ship), T Pegg

Working Group Meeting

 Updated Guidelines on Ventricular Arrhythmia in Elderly and Comorbid Patients, G Clare

Pacemaker and Implantable Cardioverter Defibrillator Implantation Practice in New Zealand, S Foo

Trends in Pacing in New Zealand and setting Key Performance Indicators, D Boddington

Workforce update, S Denekamp

Working Group Meeting

MRI, J Martin

Title to be confirmed, S Nicholls

Title to be confirmed, S Kar

1230 - 1330 Lunch
1330 - 1500 Structural Heart Symposium  Secondary Prevention/Rehabilitation
SCT  
 

Who should not have Transcatheter Aortic Valve Implantation (TAVI), J Stewart

Imaging for TAVI, R Nair

Things that TAVI cardiologists always forget about, S Galvin

Panel Discussion 

Are our Cardiac Rehab Programs meeting the needs of women?, L Worrall-Carter

National Cardiac Rehabilitation System, R Hall

 Psychologist for cardiac patients, S Young

Rehab for Spontaneous Coronary Artery Dissection and Takotsubo, M Webster

 

 

Post Graduate Diploma in Medical Technology case, C Leaupepe

Leadless pacemaker – Christchurch experience, S Denekamp

Hand held echo technology, M Oldfield

Holter/Event Recorder new technology, K Jacobsen

 
1500 - 1530 Afternoon Tea
1530 - 1700 Structural Heart Symposium (continues) Heart Failure Working Group SCT (continues)  
 

Other structural interventions, S Kar

Cardiac imaging for structural interventions, M Davis

Percutaneous management of paravalvular leaks, P Ruygrok

Panel Discussion

Heart failure in adult congenital heart disease, J Hannah

Map of medicine, L Sinclair

Multidisciplinary team resourcing for heart failure – a national survey, J Chirnside

Measuring performances, R Fisher

New Zealand heart failure registry update, J Goodson

Panel: Question and Answer Time 

Working Group Meeting

ECG-derived spatial QRS-T angle, P Gladding

Automatic chest compression device, L Simms

Masters programme, G Osbourne & TBC 

Working Group Meeting

 
Welcome Reception with moderated posters

 

Friday 15th June

0745 - 0845 AstraZeneca Sponsored
Breakfast Symposium
(Brevet Lounge)
Novartis Sponsored
Breakfast Symposium
(Morrison Room)
ANZACS QI 
Working Group Meeting

(Theatre)
  Plenary Room Morrison Room Theatre
0900 - 0905

Welcome to CSANZ, D McClean

   
0900 - 0945

Heart Foundation Lecture: 
40 years of intervention past and future,  J Ormiston

   
0945 - 1030

Young Investigator Award

1. Long-Term Outcome Of Patients From The Auckland Region With Spontaneous Coronary Artery Dissection, A Alsamarrai

2. Assessment of the Right Ventricle using 3D Reconstruction, S Ershad

3. Rescue Percutaneous Intervention in ST Elevation Myocardial Infarction-Impact of Regional Transfer Delays in the Midland Region-Time Does Matter, A Michael

4. Utilisation and Prognostic Value of Cardiac Magnetic Resonance Imaging in Myocarditis, B Wong

   
1030 - 1100 Morning Tea
1100 - 1230 Lifestyle / Prevention Structural: Transcatheter Aortic Valve Implantation (TAVI) Affiliates Awards
 

Triglyceride lowering therapies: are they ready for prime time? S Nicholls

Diabetic treatments and CV events, R Scott

Debate:
"Statin side effects are in the patient's head!"
For: S Nicholls
Against: C Florkowski

 

 

TAVI data through the centres:
Auckland, M Webster
Waikato: R Nair
Wellington: A Sasse
Christchurch: D Smyth
Dunedin: K Milburn

 Inpatient TAVI during Acute Hospital Admission with Symptomatic Severe Aortic Stenosis, B Jahangiri


Debate:
TAVI in a low risk population – will it ever be appropriate –
surgical v cardiology opinion
Speakers: D Smyth & David Shaw

Clinical research careers that can make a difference, L Worrall-Carter

 

Nursing Affiliate Investigators Award:

Is It Necessary To Fast Before Cardiac Catheterisation?, S Bacus

A nurse-led approach to the management of patients with atrial fibrillation - one decade on, J Dean

 Do Cardiac Rehabilitation Exercise Programmes In New Zealand Follow International Recommendations? C Gasparini

Measured Implementation of an Accelerated Chest Pain Diagnostic Pathway in Primary Care, T Norman

 

Technician Affiliate Investigators Award:

Waikato Hospital Experience of Magnetic Resonance Imaging for Patients with Non-MRI Conditional Pacemakers and Implantable Cardioverter Defibrillators, C Whiteley

1230 - 1330 Lunch
1230 - 1330     Rehab AGM
1330 - 1500 Anticoagulation/Stroke Transplant Electrophysiology
 

Devices, S Kar

Endovascular interventions for acute stroke, J Fink

Warfarin v New Oral Anticoagulants post PCI, G Devlin

Antiplatelet agents post STEMI fibrinolysis

The realities of donor heart availability in New Zealand, P Ruygrok

Update on New Zealand heart transplant programme: challenges and triumphs. C Wasywich

Referral for heart transplantation - who and when, S Fitzsimons

A Titin Truncation Variant Co-segregating with Rate-related Dilated Cardiomyopathy in a Large Maori Kindred, P Gladding

Panel Discussion

Holistic approach to AF treatment., Melton

Atrial Fibrillation - A Midlands Wide Audit, How Badly Are We Doing? I Ternouth

Gender and Cardiac Resynchronization Therapy, D Boddington

Permanent Pacemaker Implantation after Cardiac Surgery: Rates, Predictors and a Novel Risk Score, T Wang

His pacing, D Hooks

1500 - 1530 Afternoon Tea
1530 - 1700 Coronary Disease/ANZACS QI and debate Heart Failure Free Communications: Valvular/Imaging 
 

What the NZ Cardiologist needs to know about ANZACs QI in 2018, A Kerr

Mid-range Ejection Fraction Following Acute Coronary Syndrome: Incidence, Management and Outcomes (ANZACS-QI), D Chan

Outcomes in Working Age First-Acute Coronary Syndrome Patients: The ANZACS-QI New Zealand National Cohort, N Earle

Instantaneous Wave - free ratio guided management of coronary lesions, C Greer

Debate:
"Single vessel disease- no role for stenting!"
For: J Christiansen
Against: G Wilkins

Palliative care: Cardiology and Palliative care perspectives, R Anscombe and T Middlemiss

Heart Failure Readmission can be reduced by Heart Function Service, P Peacock

Angiotensin II Receptor Blocker Neprilysin Inhibitor therapy, R Doughty

Iron therapy, S Fitzsimons

The New Zealand Rheumatic Heart Disease Registry, N Wilson

Infective Endocarditis: A Retrospective Audit of Investigation and Management of at Risk Patients,  A Borrie

Management of Acute Coronary Syndrome (ACS) in the Elderly, H Fahmi

Does Cardiologist Co-reporting of near-normal Transthoracic Echocardiograms impact on patient management at a Tertiary Centre?,S Bhattacharyya 

CSANZ AGM - Brevet Lounge
Gala Dinner at the Christchurch Art Gallery

 

Saturday 16th June

0745 - 0845 Philips Sponsored
Breakfast Symposium
(Brevet Lounge)
Sanofi Sponsored 
Breakfast Symposium
(Morrison Room)
 
  Plenary Room Morrison Room Theatre
0900 - 1030 Mitral Valve Congenital Heart Disease Subgroups
 

Mitral physiology, J Martin

Percutaneous intervention, S Kar

Surgical intervention, G McCrystal

Mitral Valve Surgery with or without concurrent Coronary Artery Bypass Grafting: 8-year Comparative Cohort Study, T Wang

Congenital Heart Disease for the generalist, A Aitken

From 1000g to 100kg: How Does The Heart Cope? Adult Cardiovascular Consequences of Very Low Birthweight, H Bray

Imaging in Adult Congenital Heart Disease, S MacDonald

Cardiac inherited diseases, J Skinner

Gender differences in diagnosis and treatment but what’s next?, L Worrall-Carter

Five Years of a Non-Physician Cardiovascular Genetics Clinic, T Donoghue

Cardiovascular, metabolic and nutritional profiles of a Pasifika population, A Faatoese

Remote cardiac rhythm monitoring – establishing remote cardiac monitoring criteria for Embolic Stroke Unknown Source (ESUS) patients at Auckland City Hospital, R Mitchell

1030 - 1100 Morning Tea
 1100 - 1230 *Coronary Disease Imaging Pharmac: Devices and Drugs
 

Can genetics tell us anything about atherosclerosis, S Nicholls

Reperfusion Practice For ST Elevation Myocardial Infarction (STEMI) in New Zealand: Observations From ANZACS-QI, T Tun

The role of Stress as a precipitating factor in Spontaneous Coronary Artery Dissection, C Allan

Angiographic characteristics of Spontaneous Coronary Artery Dissection, C Mcalister

Confirming LV function Assessment During Acute Coronary Syndrome (ACS) Admission at BOPDHB Hospitals, J Batey

The role of invasive haemodynamics in the era of echo for valvular heart disease, S Kar

Clinical Outcomes of Tricuspid Valve (TV) Surgery for Tricuspid Regurgitation (TR): A Retrospective Study, A Khurana

Isolated Tricuspid Valve Surgery: Single-Centre 2001-2017 Experience, T Wang

CT Coronary Angiography, N van Pelt

The Variants of Takotsubo Syndrome Differ in More Ways than Just the Echo Pattern, G Watson

Market share procurement for permanent coronary drug eluting stents and Health economic assessment of Left Atrial Appendage Occlusion in a specific subset of patients, J Wyeth

Heart drugs – the missing links, J Elliott

Impact of Outcome Measure and Duration of Follow-up on the Reliability of Clinical Trials Assessing the Efficacy and Safety of Coronary Artery Stents, E Lesiawan 

A Propensity-Matched Nested Case-Control Study of Acute Coronary Syndrome Patients Genotyped for CYP2C19, P Gladding

 

1230 - 1300 Lunch
1300 - 1330 Moderated Posters
1330 - 1530 Electrophysiology Frailty Screening/Risk Scores
 

Incidental device findings, D Heaven

Implantable Cardioverter Defibrillator use in New Zealand: A 3 year Analysis from the All New Zealand Acute Coronary Syndrome- Quality Improvement Device Registry (ANZACS-QI DEVICE), S Foo

Prevalence of Depression and Anxiety among Patients with Cardiac Implantable Electronic Device (CIED), J Miranda 

Electrophysiology Studies in New Zealand: A 3 year analysis of case type and volume across New Zealand on behalf of Heart Rhythm New Zealand (HRNZ), S Foo

How to screen for atrial fibillation after stroke, TBC


Debate:

"We should do more AF ablation"
For: D Hooks
Against: D Smyth

Elderly/Frailty, R Stewart

Comparison of Octogenarians and Septuagenarians undergoing Coronary Artery Bypass Surgery, T Wang

Pulmonary hypertension, L Beckert

Body Mass Index and Clinical Outcomes in patients with Acute Coronary Syndrome, M Alfadhel 

Salbutamol Prescribing in Primary Care May Represent Undiagnosed Heart Failure, A Pope 

Is LP(a) something we should be paying attention to?, S Nicholls 

Development and Validation of a Risk Score for Patients Back in the Community After an Acute Coronary Syndrome Event, K Poppe

Screening for Cardiac Disease with Genetic risk scoring, Advanced ECG, Echocardiography, Protein Biomarkers and Metabolomics, P Gladding 

The Investigation and Treatment of Women who present with Acute Chest Pain, varies little compared with Men when stratified by risk, S Aldous 

1530 Afternoon Tea and Closing

 

Please note this program is subject to change.

© 2018 CSANZ | Conference is managed by The Conference Company

Designed & Developed by 72DPI